1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America Antibiotics Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. North America Antibiotics Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Increase in bacterial infections
- 5.1.2 Growing demand for generic antibiotics
5.2 Market Opportunities
- 5.2.1 Expansion in emerging economies
- 5.2.2 Growth in antibiotic resistance research
5.3 Future Trends
- 5.3.1 Development of next-generation antibiotics
- 5.3.2 Rise in the adoption of combination therapies
5.4 Impact of Drivers and Restraints
6. North America Antibiotics Market Regional Analysis
6.1 North America Antibiotics Market Overview
6.2 North America Antibiotics Market Revenue 2017-2027 (US$ Million)
6.3 North America Antibiotics Market Forecast Analysis
7. North America Antibiotics Market Analysis – by Drug Class
7.1 Sulfonamides
- 7.1.1 Overview
- 7.1.2 Sulfonamides: North America Antibiotics Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Aminoglycosides
- 7.2.1 Overview
- 7.2.2 Aminoglycosides: North America Antibiotics Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Carbapenem
- 7.3.1 Overview
- 7.3.2 Carbapenem: North America Antibiotics Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Macrolides
- 7.4.1 Overview
- 7.4.2 Macrolides: North America Antibiotics Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Fluoroquinolones
- 7.5.1 Overview
- 7.5.2 Fluoroquinolones: North America Antibiotics Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Penicillin
- 7.6.1 Overview
- 7.6.2 Penicillin: North America Antibiotics Market – Revenue and Forecast to 2031 (US$ Million)
7.7 Cephalosporin
- 7.7.1 Overview
- 7.7.2 Cephalosporin: North America Antibiotics Market – Revenue and Forecast to 2031 (US$ Million)
8. North America Antibiotics Market Analysis – by Action Mechanism
8.1 Mycolic Acid Inhibitors
- 8.1.1 Overview
- 8.1.2 Mycolic Acid Inhibitors: North America Antibiotics Market – Revenue and Forecast to 2027 (US$ Million)
8.2 RNA Synthesis Inhibitors
- 8.2.1 Overview
- 8.2.2 RNA Synthesis Inhibitors: North America Antibiotics Market – Revenue and Forecast to 2027 (US$ Million)
8.3 DNA Synthesis Inhibitors
- 8.3.1 Overview
- 8.3.2 DNA Synthesis Inhibitors: North America Antibiotics Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Protein Synthesis Inhibitors
- 8.4.1 Overview
- 8.4.2 Protein Synthesis Inhibitors: North America Antibiotics Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Cell Wall Synthesis Inhibitors
- 8.5.1 Overview
- 8.5.2 Cell Wall Synthesis Inhibitors: North America Antibiotics Market – Revenue and Forecast to 2027 (US$ Million)
9. North America Antibiotics Market – North America Analysis
9.1 North America
- 9.1.1 North America Antibiotics Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 9.1.1.1 North America Antibiotics Market – Revenue and
Forecast Analysis – by Country
- 9.1.1.1 US:
North America Antibiotics Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.1.1 US: North America Antibiotics Market Breakdown, by Drug Class
- 9.1.1.1.2 US: North America Antibiotics Market Breakdown, by Action Mechanism
- 9.1.1.2 Canada:
North America Antibiotics Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.2.1 Canada: North America Antibiotics Market Breakdown, by Drug Class
- 9.1.1.2.2 Canada: North America Antibiotics Market Breakdown, by Action Mechanism
- 9.1.1.3 Mexico :
North America Antibiotics Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.3.1 Mexico : North America Antibiotics Market Breakdown, by Drug Class
- 9.1.1.3.2 Mexico : North America Antibiotics Market Breakdown, by Action Mechanism
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. North America Antibiotics Market Industry Landscape
11.1 Overview
11.2 Mergers and Acquisitions
11.3 Agreements, Collaborations, and Joint Ventures
11.4 New Product Launches
11.5 Expansions and Other Strategic Developments
12. Company Profiles
12.1 Johnson & Johnson Services, Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Bristol-Myers Squibb Company
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Eli Lilly and Company.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Abbott
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Pfizer Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
13. Appendix
13.1 About Business Market Insights
Get Free Sample For North America Antibiotics Market
